Teva Identifies Teriparatide Importance Amid US Launch Drought

Israeli Firm Sees 15% North America Gx Sales Decline In Q1

 
• By Dean Rudge
  
Balloons
Teva singled out teriparatide among its 2022 opportunities • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business